Stacey L. Amorosi - Concepedia

Author

Stacey L. Amorosi

Boston Scientific (United States)

Also Known As

S. Amorosi, S.L. Amorosi, STACEY L. AMOROSI, Stacey Amorosi, Stacey L Amorosi, Stacey L. Amorosi

Publications

634

Citations

H-Index

Concepts

All Affiliations

Boston Scientific (United States)University of Sheffield BresMed GfK (United States)Icahn School of Medicine at Mount Sinai

About

Stacey L. Amorosi is an author at Boston Scientific (United States) specializing in medicine, outcomes research, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	325
2	Public Health	2	2	177
3	Health Policy	2	2	177
4	Emergency Medicine	1	1	45
5	Neurology	1	1	95

Stacey L. Amorosi

Publications

560

Citations

H-Index

Page 1

	Year	Citations
Patterns of endoscopy in the United States: analysis of data from the Centers for Medicare and Medicaid Services and the National Endoscopic Database Amnon Sonnenberg, Stacey L. Amorosi, Michael J. Lacey, Gastrointestinal Endoscopy EndoscopyHealth PolicyEndoscopic SurgeryMedicineInterventional Endoscopic Ultrasound	2008	132
Time to Cost-Effectiveness Following Stroke Reduction Strategies in AF Vivek Y. Reddy, R. Akehurst, Shannon Armstrong, Journal of the American College of Cardiology Stroke RehabilitationIschemic StrokeMedicineStroke-related ConditionCerebrovascular Disease	2015	95
Cost analysis of “bridging therapy” with low-molecular-weight heparin versus unfractionated heparin during temporary interruption of chronic anticoagulation Stacey L. Amorosi, Kanella Tsilimingras, David R. Thompson, The American Journal of Cardiology ThrombosisHematologyHemostasisChronic AnticoagulationPharmacotherapy	2004	53
Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin Vivek Y. Reddy, R. Akehurst, Shannon Armstrong, EP Europace	2016	51
Cost‐Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5‐Year, Long‐Term Data Vivek Y. Reddy, R. Akehurst, Meghan Gavaghan, Journal of the American Heart Association Heart FailureStroke ReductionAcute Myocardial InfarctionThrombosisStroke Rehabilitation	2019	45
Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non–Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation Vivek Y. Reddy, R. Akehurst, Stacey L. Amorosi, Stroke	2018	44
Evaluation of Patients' Preferences for Triamcinolone Acetonide Aqueous, Fluticasone Propionate, and Mometasone Furoate Nasal Sprays in Patients with Allergic Rhinitis Michael Stokes, Stacey L. Amorosi, David R. Thompson, Otolaryngology	2004	34
Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia Bilal Chughtai, Sirikan Rojanasarot, Kurt Neeser, Journal of health economics and outcomes research	2021	26
An Analysis of a Commercial Database on the Use of Erectile Dysfunction Treatments for Men With Employer-Sponsored Health Insurance Arthur L. Burnett, Sirikan Rojanasarot, Stacey L. Amorosi Urology	2020	24
Outcomes and costs of remote patient monitoring among patients with implanted cardiac defibrillators: An economic model based on the PREDICT RM database James P. Hummel, Robert J. Leipold, Stacey L. Amorosi, Journal of Cardiovascular Electrophysiology	2019	22

Page 1